Skip to main content

Child Health clinical trials at UCSF

1 in progress, 0 open to eligible people

Showing trials for
  • Azithromycin for Child Survival in Niger: Programmatic Trial (AVENIR)

    Sorry, not yet accepting patients

    The MORDOR trial found that biannual distribution of azithromycin to children 1-59 months old reduced child mortality. The World Health Organization (WHO) released conditional guidelines for this intervention, which include targeting azithromycin distributions to children 1-11 months of age in high mortality settings. The proposed trial aims to demonstrate and evaluate large-scale implementation of azithromycin to children aged 1-11 months old in the context of a programmatic setting while monitoring mortality and resistance antimicrobial resistance.

Our lead scientists for Child Health medical studies include .

Last updated: